Literature DB >> 28967511

Does surgical site infection after Caesarean section in Polish hospitals reflect high-quality patient care or poor postdischarge surveillance? Results from a 3-year multicenter study.

Anna Różańska1, Andrzej Jarynowski2, Katarzyna Kopeć-Godlewska3, Jadwiga Wójkowska-Mach4, Agnieszka Misiewska-Kaczur5, Marzena Lech6, Małgorzata Rozwadowska7, Marlena Karwacka8, Joanna Liberda9, Joanna Domańska10.   

Abstract

BACKGROUND: Caesarean sections (CSs) are associated with a high infection risk. Surgical site infection (SSI) incidence is among the markers of effectiveness of infection prevention efforts. The aim of this study was to analyze risk factors for SSI, incidence, and microbiology in patients who underwent CS.
METHODS: The study was conducted during 2013-2015 using active infection surveillance in 5 Polish hospitals according to the European Centre for Disease Prevention and Control surveillance network known as HAI-Net. For each procedure, the following data were registered: age, American Society of Anesthesiologists score, procedure time, elective or emergency procedure, use of perioperative antibiotic prophylaxis, microbiology, the treatment used, and other information.
RESULTS: SSI incidence was 0.5% and significant differences were noted among hospitals (between 0.1% and 1.8%), for different American Society of Anesthesiologists scales (between 0.2% and 4.8%) and different values of standardized SSI risk index (between 0.0% and 0.8%). In 3.1% of procedures, with no antibiotic prophylaxis, SSI risk was significantly higher. Deep infections dominated: 61.5% with superficial infections in only approximately 30% of cases and 2.6% of infections were detected postdischarge without readmissions.
CONCLUSIONS: Results showed high incidence of SSI in Poland without perioperative antibiotic prophylaxis, and secondly, ineffective surveillance according to CS status, considering outpatient obstetric care. Without postdischarge surveillance, it is not possible to recognize the epidemiologic situation, and further, to set priorities and needs when it comes to infection prophylaxis, especially because such low incidence may indicate no need for improvement in infection control.
Copyright © 2018 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ASA score; Duration of surgery; Healthcare associated infections; Incidence study; Obstetric; Perioperative antibiotic prophylaxis

Mesh:

Substances:

Year:  2017        PMID: 28967511     DOI: 10.1016/j.ajic.2017.07.025

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  10 in total

1.  Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.

Authors:  Michał Wałaszek; Anna Różańska; Marta Zofia Wałaszek; Jadwiga Wójkowska-Mach
Journal:  BMC Infect Dis       Date:  2018-07-06       Impact factor: 3.090

2.  Interest in Working as an Infection Prevention and Control Nurse and Perception of This Position by Nursing Students-Results of a Pilot Study.

Authors:  Dorota Jaślan; Jerzy Rosiński; Małgorzata Siewierska; Anna Szczypta; Marta Wałaszek; Jadwiga Wójkowska-Mach; Agnieszka Gniadek; Renata Majewska; Anna Różańska
Journal:  Int J Environ Res Public Health       Date:  2020-10-29       Impact factor: 3.390

3.  Outpatient Antibiotic Prescriptions in Pregnant Women in Małopolska Province.

Authors:  Anna Różańska; Agnieszka Pac; Estera Jachowicz; Dorota Jaślan; Małgorzata Siewierska; Jadwiga Wójkowska-Mach
Journal:  Antibiotics (Basel)       Date:  2020-12-26

4.  Incidence of Surgical Site Infections in Multicenter Study-Implications for Surveillance Practice and Organization.

Authors:  Anna Różańska; Jerzy Rosiński; Andrzej Jarynowski; Katarzyna Baranowska-Tateno; Małgorzata Siewierska; Jadwiga Wójkowska-Mach; Polish Society Of Hospital Infections Team
Journal:  Int J Environ Res Public Health       Date:  2021-05-18       Impact factor: 3.390

5.  Hospital-Wide Surveillance of Healthcare-Associated Infections as a Source of Information about Specific Hospital Needs. A 5-Year Observation in a Multiprofile Provincial Hospital in the South of Poland.

Authors:  Małgorzata Kołpa; Marta Wałaszek; Anna Różańska; Zdzisław Wolak; Jadwiga Wójkowska-Mach
Journal:  Int J Environ Res Public Health       Date:  2018-09-07       Impact factor: 3.390

6.  Can surgical site infections be controlled through microbiological surveillance? A three-year laboratory-based surveillance at an orthopaedic unit, retrospective observatory study.

Authors:  Iwona Pawłowska; Grzegorz Ziółkowski; Jadwiga Wójkowska-Mach; Tomasz Bielecki
Journal:  Int Orthop       Date:  2019-01-24       Impact factor: 3.075

7.  Epidemiology of Surgical Site Infections Considering the NHSN Standardized Infection Ratio in Hip and Knee Arthroplasties.

Authors:  Róża Słowik; Małgorzata Kołpa; Marta Wałaszek; Anna Różańska; Barbara Jagiencarz-Starzec; Witold Zieńczuk; Łukasz Kawik; Zdzisław Wolak; Jadwiga Wójkowska-Mach
Journal:  Int J Environ Res Public Health       Date:  2020-05-02       Impact factor: 3.390

8.  Incidence of Surgical Site Infection and Factors Associated among Cesarean Deliveries in Selected Government Hospitals in Addis Ababa, Ethiopia, 2019.

Authors:  Hana Lijaemiro; Semarya Berhe Lemlem; Jembere Tesfaye Deressa
Journal:  Obstet Gynecol Int       Date:  2020-02-22

9.  Surgical site infections following caesarean sections at Emirati teaching hospital: Incidence and implicated factors.

Authors:  Munther S Alnajjar; Dalia A Alashker
Journal:  Sci Rep       Date:  2020-10-30       Impact factor: 4.379

10.  Post-Discharge Clostridioides difficile Infection after Arthroplasties in Poland, Infection Prevention and Control as the Key Element of Prevention of C. difficile Infections.

Authors:  Estera Jachowicz; Agnieszka Pac; Anna Różańska; Barbara Gryglewska; Jadwiga Wojkowska-Mach
Journal:  Int J Environ Res Public Health       Date:  2022-03-08       Impact factor: 3.390

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.